Scarica l'app Stockscreener
5.165
0.00%
0.005
Precedente Chiudi:
$5.16
Aprire:
$5.15
Volume 24 ore:
17,663
Relative Volume:
0.02
Capitalizzazione di mercato:
$232.31M
Reddito:
-
Utile/perdita netta:
$-32.74M
Rapporto P/E:
-6.2988
EPS:
-0.82
Flusso di cassa netto:
$-24.89M
1 W Prestazione:
+0.19%
1M Prestazione:
+48.28%
6M Prestazione:
-61.12%
1 anno Prestazione:
-56.12%
Intervallo 1D:
$5.15
$5.17
Intervallo di 1 settimana:
$5.112
$5.25
Portata 52W:
$3.18
$16.94
Third Harmonic Bio Inc Stock (THRD) Company Profile
Nome
Third Harmonic Bio Inc
Settore
Industria
Telefono
(209) 727-2457
Indirizzo
1700 MONTGOMERY STREET, SAN FRANCISCO
Confronta THRD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
THRD
Third Harmonic Bio Inc
|
5.16 | 232.31M | 0 | -32.74M | -24.89M | -0.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
454.79 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
596.63 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
650.75 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
269.75 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.49 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Third Harmonic Bio Inc Stock (THRD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-28 | Downgrade | Stifel | Buy → Hold |
| 2025-02-12 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-02-11 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2024-08-09 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-06-18 | Iniziato | Stifel | Buy |
| 2024-06-07 | Iniziato | Raymond James | Outperform |
| 2022-12-16 | Downgrade | Jefferies | Buy → Hold |
| 2022-12-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-10-10 | Iniziato | Cowen | Outperform |
| 2022-10-10 | Iniziato | Jefferies | Buy |
| 2022-10-10 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Third Harmonic Bio Inc Borsa (THRD) Ultime notizie
Third Harmonic Bio Announces Plan of Liquidation and Dissolution - ADVFN
Here’s Why Third Harmonic Bio (THRD) Fell in Q1 - Insider Monkey
Third Harmonic Bio’s CSO Christopher Dinsmore Steps Down - MSN
Fierce Biotech Layoff Tracker 2025: Caribou cuts 32% of staff; Mural lays off 90% - Fierce Biotech
Third Harmonic Bio CSO steps down, enters separation agreement - Investing.com Australia
Third Harmonic Bio CSO steps down, enters separation agreement By Investing.com - Investing.com India
New fund Alis offers struggling biotechs an off-ramp: Finance Report - BioCentury
Finance Watch: Investors Push ESSA Pharma, Elevation Oncology To Wind Down - insights.citeline.com
SF biotech company, once worth nearly $1 billion, plans to shut down - SFGATE
Biotech Alert: Searches spiking for these stocks today - TipRanks
Third Harmonic Bio (THRD) Plans Liquidation; Significant Search Surge in Biotech Sector | ARTL Stock News - GuruFocus
Third Harmonic Bio (THRD) Seeks Stockholder Approval for Liquida - GuruFocus
Third Harmonic Bio plans to liquidate the company, sell urticaria treatment - MSN
Third Harmonic Bio, Inc. Liquidation and Shareholder Distribution: Analyst Maintains Hold Rating Amid Strategic Uncertainties - TipRanks
Third Harmonic's shutdown, Coherus and Xoma drug sales connectedBizwomen - The Business Journals
Third Harmonic Bio leaps as it reveals liquidation plan - The Pharma Letter
Big moves by small biotechs signal potential shift for investorsSan Francisco Business Times - The Business Journals
Top 3 Health Care Stocks You May Want To Dump This Quarter - Benzinga
Third Harmonic Bio Announces Liquidation Plan: Stock Skyrockets 39% Pre-Market, But Retail’s Shattered - MSN
$26bn Brighton Jones hires new CFO - Citywire
Third Harmonic Bio plans liquidation and asset sale By Investing.com - Investing.com South Africa
Third Harmonic Bio, Apple, Dell And Other Big Stocks Moving Higher In Monday's Pre-Market Session (CORRECTED) - Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Third Harmonic outlines plans for dissolution - BioPharma Dive
Third Harmonic Bio sees initial distribution of $5.13-$5.33 from liquidation - TipRanks
Third Harmonic Bio stock holds as liquidation plan unveiled By Investing.com - Investing.com Canada
Third Harmonic Bio Stock Is Up 40% Monday: What's Happening?Third Harmonic Bio (NASDAQ:THRD) - Benzinga
Third Harmonic Announces Liquidation And Cash Return, Stock Jumps - Nasdaq
Third Harmonic to shutter; Future Pak once again targets Theratechnologies - Endpoints News
THRD’s Ambitious Moves: From Trials to Strategies? - timothysykes.com
Third Harmonic Bio Plans Liquidation With Lucrative Payouts - Finimize
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Third Harmonic Bio announces plan of liquidation and dissolution - TipRanks
Third Harmonic Seeks to Liquidate, Dissolve Company - marketscreener.com
Third Harmonic Bio Announces Plan Of Liquidation And Dissolution - marketscreener.com
Third Harmonic Bio plans liquidation and asset sale - Investing.com Australia
Third Harmonic Bio to Return $255M to Shareholders in Major Cash Distribution - Stock Titan
Layoff Tracker: Opthea Slashes 65% of Staff, Pfizer Cuts 56 - BioSpace
Third Harmonic stock rating cut by Raymond James - MSN
Third Harmonic Bio Inc Azioni (THRD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Third Harmonic Bio Inc Azioni (THRD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Conner Edward R. | Chief Medical Officer |
Nov 08 '24 |
Sale |
15.00 |
2,117 |
31,755 |
0 |
| BVF PARTNERS L P/IL | See Explanation of Responses |
Oct 29 '24 |
Sale |
14.30 |
1,000,000 |
14,300,000 |
176,692 |
| Conner Edward R. | Chief Medical Officer |
Oct 28 '24 |
Option Exercise |
4.20 |
2,673 |
11,227 |
2,673 |
| Conner Edward R. | Chief Medical Officer |
Oct 28 '24 |
Sale |
15.00 |
2,673 |
40,095 |
0 |
1.72%
0.85%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):